Zhongjin Kangrui Medical Industrial Fund
3
123M
3
2
2
- Stages of investment
- Areas of investment
Summary
Among the most popular fund investment industries, there are Internet, Medical. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Chemclin, Genetron Health, UNIMED.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Zhongjin Kangrui Medical Industrial Fund, startups are often financed by Legend Star, WI Harper Group, Matrix Partners China. The meaningful sponsors for the fund in investment in the same round are V Star Capital, Shenshang Xingye Fund, Ping An Ventures. In the next rounds fund is usually obtained by Vivo Capital, Highlight Capital, Alexandria Venture Investments.
Deals in the range of more than 100 millions dollars are the general things for fund. Opposing the other organizations, this Zhongjin Kangrui Medical Industrial Fund works on 4 percentage points more the average amount of lead investments. The higher amount of exits for fund were in 2013. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2018. Speaking about the real fund results, this VC is 47 percentage points more often commits exit comparing to other organizations.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 2
- Exits
- 2
- Investments by industry
- Health Care (3)
- Medical (2)
- Internet (1)
- Biotechnology (1)
- Health Diagnostics (1) Show 2 more
- Investments by region
-
- China (3)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 12
- Group Appearance index
- 0.67
- Avg. company exit year
- 14
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Genetron Health | 04 Jan 2018 | Health Care, Medical Device, Medical, Clinical Trials | Late Stage Venture | 61M | Beijing, Dongcheng District, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.